Osteoporosis Disease Management Demonstration Project

This study is ongoing, but not recruiting participants.

Sponsored by:	Merck
Information provided by:	Merck
ClinicalTrials.gov Identifier:	NCT00139425

Purpose

The purpose of this study is to assess the impact of disease management interventions on bone mineral density (BMD) screening rates and osteoporosis treatment rates in women age 65 years or older.

Condition	Intervention
Osteoporosis	Behavioral: Disease Management Assessment

MedlinePlus related topics: Minerals Osteoporosis

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Educational/Counseling/Training, Randomized, Open Label, Placebo Control, Parallel Assignment
Official Title:	Osteoporosis Prevention and Treatment Program: A Disease Management Demonstration Project

Further study details as provided by Merck:

Primary Outcome Measures:

Bone mineral density (BMD) testing rates

Secondary Outcome Measures:

Osteoporosis medication treatment rates

Estimated Enrollment:	10000
Study Start Date:	May 2003

Eligibility

Ages Eligible for Study:	65 Years to 89 Years
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Members of the Henry Ford Health System

Exclusion Criteria:

Individuals who are not members of the Henry Ford Health System

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00139425

Sponsors and Collaborators

Merck

Investigators

Study Director:

Medical Monitor

Merck

More Information

Publications indexed to this study:

Lafata JE, Kolk D, Peterson EL, McCarthy BD, Weiss TW, Chen YT, Muma BK. Improving osteoporosis screening: results from a randomized cluster trial. J Gen Intern Med. 2007 Mar;22(3):346-51.

Study ID Numbers:	2005_048
Study First Received:	August 29, 2005
Last Updated:	September 7, 2005
ClinicalTrials.gov Identifier:	NCT00139425
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Musculoskeletal Diseases
Osteoporosis
Bone Diseases, Metabolic
Bone Diseases

ClinicalTrials.gov processed this record on January 16, 2009